ProfileGDS4718 / 216871_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 9% 12% 10% 15% 8% 14% 12% 14% 12% 10% 12% 7% 11% 5% 7% 9% 13% 7% 9% 14% 11% 11% 10% 4% 10% 15% 4% 10% 8% 15% 20% 12% 7% 12% 12% 13% 13% 11% 12% 11% 13% 17% 10% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.748939
GSM549102patient 115, normal, homogenized [OPG study]3.8582512
GSM549104patient 119, normal, homogenized [OPG study]3.7736810
GSM549108patient 138, normal, homogenized [OPG study]3.9931415
GSM549119patient 077, normal, homogenized [OPG study]3.717918
GSM549133patient 032, cancer, homogenized [OPG study]3.8727114
GSM549139patient 042, cancer, homogenized [OPG study]3.8343912
GSM549099patient 107, normal, homogenized [OPG study]3.9212114
GSM549109patient 139, normal, homogenized [OPG study]3.8809812
GSM549110patient 046, normal, homogenized [OPG study]3.7796910
GSM549114patient 063, normal, homogenized [OPG study]3.8262312
GSM549122patient 082, normal, homogenized [OPG study]3.692337
GSM549134patient 033, cancer, homogenized [OPG study]3.8199911
GSM549136patient 036, cancer, homogenized [OPG study]3.556845
GSM549140patient 044, cancer, homogenized [OPG study]3.637627
GSM549111patient 047, normal, homogenized [OPG study]3.725359
GSM549113patient 057, normal, homogenized [OPG study]3.8645213
GSM549132patient 031, cancer, homogenized [OPG study]3.658157
GSM549137patient 038, cancer, homogenized [OPG study]3.733979
GSM549142patient 047, cancer, homogenized [OPG study]3.9978514
GSM549100patient 110, normal, homogenized [OPG study]3.8107611
GSM549107patient 135, normal, homogenized [OPG study]3.7862311
GSM549115patient 068, normal, homogenized [OPG study]3.7632610
GSM549116patient 072, normal, homogenized [OPG study]3.533914
GSM549120patient 078, normal, homogenized [OPG study]3.78110
GSM549131patient 030, cancer, homogenized [OPG study]3.9054915
GSM549118patient 074, normal, homogenized [OPG study]3.566444
GSM549129patient 027, cancer, homogenized [OPG study]3.7837710
GSM549123patient 088, normal, homogenized [OPG study]3.709548
GSM549124patient 006, cancer, homogenized [OPG study]3.9844315
GSM549126patient 015, cancer, homogenized [OPG study]4.1297220
GSM549128patient 025, cancer, homogenized [OPG study]3.8166612
GSM549103patient 117, normal, homogenized [OPG study]3.672147
GSM549117patient 073, normal, homogenized [OPG study]3.8586712
GSM549138patient 041, cancer, homogenized [OPG study]3.827412
GSM549141patient 045, cancer, homogenized [OPG study]3.8352613
GSM549130patient 028, cancer, homogenized [OPG study]3.8853113
GSM549101patient 111, normal, homogenized [OPG study]3.7957211
GSM549105patient 128, normal, homogenized [OPG study]3.8474212
GSM549106patient 134, normal, homogenized [OPG study]3.7782311
GSM549112patient 048, normal, homogenized [OPG study]3.8900713
GSM549125patient 011, cancer, homogenized [OPG study]4.032417
GSM549127patient 024, cancer, homogenized [OPG study]3.7739310
GSM549135patient 035, cancer, homogenized [OPG study]3.8282813